Numerous reports have demonstrated that exposure of ERα expressing breast cancer cells to estrogen results in increased rates of proliferation while more recent studies have suggested that expression of ERβ alone [21,24,25], or in combination with ERα [26-28], inhibits cell proliferation following estrogen exposure. Here, ESR2 is linked to breast carcinoma.